e-learning
resources
London 2016
Monday, 05.09.2016
Clinical and molecular studies in asthma
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
A novel, automated periostin assay; correlation with a commercial ELISA method and usability as an asthma biomarker
Masayuki Takai (Sagamihara, Japan), Masayuki Takai, Junya Ono, Ayami Kamei, Hisako Matsumoto, Shoichiro Ohta, Kenji Izuhara
Source:
International Congress 2016 – Clinical and molecular studies in asthma
Session:
Clinical and molecular studies in asthma
Session type:
Oral Presentation
Number:
1980
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Masayuki Takai (Sagamihara, Japan), Masayuki Takai, Junya Ono, Ayami Kamei, Hisako Matsumoto, Shoichiro Ohta, Kenji Izuhara. A novel, automated periostin assay; correlation with a commercial ELISA method and usability as an asthma biomarker. Eur Respir J 2016; 48: Suppl. 60, 1980
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
A new investigational use only automated immunoassay for periostin
Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections
Year: 2015
Performance evaluation of a novel point-of-care total IgE assay system in atopic patients
Source: International Congress 2016 – Laboratory tests and cell biology in allergy and immunology
Year: 2016
Performance characteristics of an ECL immunoassay for the quantitation of serum periostin
Source: International Congress 2016 – Exploring mechanisms in health and disease
Year: 2016
A solution to small samples: A method validation study for sputum assay
Source: International Congress 2014 – More paediatric asthma
Year: 2014
Usefulness of periostin as a biomarker of pediatric asthma
Source: International Congress 2015 – Paediatric asthma and allergy: lung function and biomarkers
Year: 2015
Diagnostic accuracy of markers for detection of airway eosinophilia in asthma: A systematic review
Source: International Congress 2014 – Airway biomarkers
Year: 2014
Comparison of the analytical performance of the Euroline®, ImmunoCAP®, and ImmunoCAP ISAC 112® in vitro allergen sIgE diagnostic assays in the pediatric arm of the DZL All Age Asthma Cohort (ALLIANCE)
Source: International Congress 2018 – Paediatric asthma: new mechanisms and tools
Year: 2018
A new method for performing specific challenge tests to chlorine-releasing agents
Source: International Congress 2016 – Occupational epidemiology
Year: 2016
Novel proteomic biomarkers in the evaluation of childhood asthma
Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules
Year: 2013
Methacholine challenge test in asthma: Serial measurement and clinical significance
Source: Annual Congress 2013 –Monitoring lung function in airway diseases
Year: 2013
Usefulness of exhaled breath condensate as non-invasive method of evaluating of biomarkers in severe asthma patients
Source: International Congress 2014 – Biomarkers of asthma and clinical immunology
Year: 2014
Refined severity assessment of asthmatic children using molecular allergy diagnostics
Source: Annual Congress 2013 –Uncontrolled and severe asthma in children
Year: 2013
Global evaluation of treatment effectiveness (GETE) is an accurate predictor of response to omalizumab in patients with severe allergic asthma: A pooled analysis
Source: International Congress 2014 – Intervening in allergic asthma
Year: 2014
Long-term efficacy of omalizumab (OMA) for patients with severe allergic asthma (SAA). Clinical assessment and relationship to serum IgE concentrations
Source: International Congress 2015 – The immunology of allergic airway disease
Year: 2015
Unbiased cluster analysis of severe asthma based on metabolomics by the U-BIOPRED electronic nose platform
Source: Annual Congress 2013 –Asthma and COPD: diseases with different phenotypes
Year: 2013
Sputum YKL-40 is a potential biomarker of COPD-asthma overlap
Source: International Congress 2014 – Systemic and airway biomarkers
Year: 2014
A new observer independent method to assess therapy response in children with severe asthma based on daily lung function
Source: Annual Congress 2013 –Uncontrolled and severe asthma in children
Year: 2013
LATE-BREAKING ABSTRACT: The study of fibulin-1 as a novel biomarker in bronchial asthma and its association to disease severity
Source: International Congress 2015 – Emerging strategies for airway disease treatments
Year: 2015
Asthma phenotypes determined by a novel fluctuation based clustering method using a time window of lung function observations
Source: International Congress 2015 – Understanding paediatric asthma and allergy: genetics and environment
Year: 2015
Proteome fingerprints define groups with distinct clinico-pathological phenotypes in the U-BIOPRED asthma study
Source: International Congress 2016 – What's new in biomarker analysis?
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept